A citation-based method for searching scientific literature

Andrea de Bartolomeis, Mirko Manchia, Federica Marmo, Licia Vellucci, Felice Iasevoli, Annarita Barone. Front Psychiatry 2020
Times Cited: 5







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia: a randomized, double-blind, proof-of-concept study.
Daniel Umbricht, Daniela Alberati, Meret Martin-Facklam, Edilio Borroni, Eriene A Youssef, Michael Ostland, Tanya L Wallace, Frédéric Knoflach, Ernest Dorflinger, Joseph G Wettstein,[...]. JAMA Psychiatry 2014
136
40

Bitopertin in Negative Symptoms of Schizophrenia-Results From the Phase III FlashLyte and DayLyte Studies.
Dragana Bugarski-Kirola, Thomas Blaettler, Celso Arango, Wolfgang W Fleischhacker, George Garibaldi, Alice Wang, Mark Dixon, Rodrigo A Bressan, Henry Nasrallah, Stephen Lawrie,[...]. Biol Psychiatry 2017
40
40

D-alanine added to antipsychotics for the treatment of schizophrenia.
Guochuan E Tsai, Pinchen Yang, Yue-Cune Chang, Mian-Yoon Chong. Biol Psychiatry 2006
131
20


Converting positive and negative symptom scores between PANSS and SAPS/SANS.
Theo G M van Erp, Adrian Preda, Dana Nguyen, Lawrence Faziola, Jessica Turner, Juan Bustillo, Aysenil Belger, Kelvin O Lim, Sarah McEwen, James Voyvodic,[...]. Schizophr Res 2014
73
20

Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia.
Hsien-Yuan Lane, Chieh-Liang Huang, Po-Lun Wu, Yi-Ching Liu, Yue-Cune Chang, Pao-Yen Lin, Po-Wei Chen, Guochuan Tsai. Biol Psychiatry 2006
116
20

The method quality of cross-over studies involved in Cochrane Systematic Reviews.
Hong Ding, Guang Li Hu, Xue Yan Zheng, Qing Chen, Diane Erin Threapleton, Zeng Huan Zhou. PLoS One 2015
49
20

A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia.
D C Goff, G Tsai, J Levitt, E Amico, D Manoach, D A Schoenfeld, D L Hayden, R McCarley, J T Coyle. Arch Gen Psychiatry 1999
306
20

Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia.
U Heresco-Levy, D C Javitt, M Ermilov, C Mordel, G Silipo, M Lichtenstein. Arch Gen Psychiatry 1999
352
20

Feasibility, safety, and efficacy of the combination of D-serine and computerized cognitive retraining in schizophrenia: an international collaborative pilot study.
Deepak C D'Souza, Rajiv Radhakrishnan, Edward Perry, Savita Bhakta, Nagendra M Singh, Richa Yadav, Danielle Abi-Saab, Brian Pittman, Santosh K Chaturvedi, Mahendra P Sharma,[...]. Neuropsychopharmacology 2013
49
20

The effects of glycine on auditory mismatch negativity in schizophrenia.
Lisa-Marie Greenwood, Sumie Leung, Patricia T Michie, Amity Green, Pradeep J Nathan, Paul Fitzgerald, Patrick Johnston, Nadia Solowij, Jayashri Kulkarni, Rodney J Croft. Schizophr Res 2018
22
20

A six-month, placebo-controlled trial of D-cycloserine co-administered with conventional antipsychotics in schizophrenia patients.
Donald C Goff, Lawrence Herz, Thomas Posever, Vivian Shih, Guochuan Tsai, David C Henderson, Oliver Freudenreich, A Eden Evins, Iftah Yovel, Hui Zhang,[...]. Psychopharmacology (Berl) 2005
86
20

Association between serum levels of glutamate and neurotrophic factors and response to clozapine treatment.
Amir Krivoy, Eldar Hochman, Kyra-Verena Sendt, Sarah Hollander, Yael Vilner, Mirjana Selakovic, Abraham Weizman, Michal Taler. Schizophr Res 2018
12
20

Dopamine and glutamate in schizophrenia: biology, symptoms and treatment.
Robert A McCutcheon, John H Krystal, Oliver D Howes. World Psychiatry 2020
72
20

Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: Correlation with symptoms.
Joshua T Kantrowitz, Michael L Epstein, Migyung Lee, Nayla Lehrfeld, Karen A Nolan, Constance Shope, Eva Petkova, Gail Silipo, Daniel C Javitt. Schizophr Res 2018
50
20

Glutamatergic neurometabolites and cortical thickness in treatment-resistant schizophrenia: Implications for glutamate-mediated excitotoxicity.
Parita Shah, Eric Plitman, Yusuke Iwata, Julia Kim, Shinichiro Nakajima, Nathan Chan, Eric E Brown, Fernando Caravaggio, Edgardo Torres, Margaret Hahn,[...]. J Psychiatr Res 2020
7
20


D-cycloserine adjuvant therapy to molindone in the treatment of schizophrenia.
R B Rosse, M Fay-McCarthy, K Kendrick, R E Davis, S I Deutsch. Clin Neuropharmacol 1996
46
20

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.
Oliver D Howes, Rob McCutcheon, Ofer Agid, Andrea de Bartolomeis, Nico J M van Beveren, Michael L Birnbaum, Michael A P Bloomfield, Rodrigo A Bressan, Robert W Buchanan, William T Carpenter,[...]. Am J Psychiatry 2017
318
20

Amelioration of negative symptoms in schizophrenia by glycine.
D C Javitt, I Zylberman, S R Zukin, U Heresco-Levy, J P Lindenmayer. Am J Psychiatry 1994
286
20



Association of schizophrenia onset age and white matter integrity with treatment effect of D-cycloserine: a randomized placebo-controlled double-blind crossover study.
Kazuo Takiguchi, Akihito Uezato, Michio Itasaka, Hidenori Atsuta, Kenji Narushima, Naoki Yamamoto, Akeo Kurumaji, Makoto Tomita, Kazunari Oshima, Kosaku Shoda,[...]. BMC Psychiatry 2017
10
20

Meta-analyses involving cross-over trials: methodological issues.
Diana R Elbourne, Douglas G Altman, Julian P T Higgins, Francois Curtin, Helen V Worthington, Andy Vail. Int J Epidemiol 2002
20

Adjunctive high-dose glycine in the treatment of schizophrenia.
D C Javitt, G Silipo, A Cienfuegos, A M Shelley, N Bark, M Park, J P Lindenmayer, R Suckow, S R Zukin. Int J Neuropsychopharmacol 2001
122
20

A Pilot Randomized, Placebo-Controlled Trial of Glycine for Treatment of Schizophrenia and Alcohol Dependence.
Jane Serrita, Elizabeth Ralevski, Gihyun Yoon, Ismene Petrakis. J Dual Diagn 2019
3
33

Methodological advantages and disadvantages of parallel and crossover randomised clinical trials on methylphenidate for attention deficit hyperactivity disorder: a systematic review and meta-analyses.
Helle B Krogh, Ole Jakob Storebø, Erlend Faltinsen, Adnan Todorovac, Erica Ydedahl-Jensen, Frederik Løgstrup Magnusson, Mathilde Holmskov, Trine Gerner, Christian Gluud, Erik Simonsen. BMJ Open 2019
8
20

Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia.
Uriel Heresco-Levy, Marina Ermilov, Jonathan Shimoni, Baruch Shapira, Gail Silipo, Daniel C Javitt. Am J Psychiatry 2002
146
20

Antipsychotic Polypharmacy in Schizophrenia: Why Not?
Daniel Guinart, Christoph U Correll. J Clin Psychiatry 2020
7
20

Placebo-controlled trial of glycine added to clozapine in schizophrenia.
A E Evins, S M Fitzgerald, L Wine, R Rosselli, D C Goff. Am J Psychiatry 2000
126
20


Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: an exploratory study.
Donald C Goff, Corinne Cather, Jennifer D Gottlieb, A Eden Evins, Jared Walsh, Lisa Raeke, Michael W Otto, David Schoenfeld, Michael F Green. Schizophr Res 2008
93
20

Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia.
Guochuan Tsai, Hsien-Yuan Lane, Pinchen Yang, Mian-Yoon Chong, Nicholas Lange. Biol Psychiatry 2004
258
20

Recent advances in the phencyclidine model of schizophrenia.
D C Javitt, S R Zukin. Am J Psychiatry 1991
20

Placebo response in antipsychotic clinical trials: a meta-analysis.
Bret R Rutherford, Emily Pott, Jane M Tandler, Melanie M Wall, Steven P Roose, Jeffrey A Lieberman. JAMA Psychiatry 2014
84
20

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. J Clin Epidemiol 2009
20


Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia.
U Heresco-Levy, D C Javitt, M Ermilov, C Mordel, A Horowitz, D Kelly. Br J Psychiatry 1996
197
20

Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study.
Hsien-Yuan Lane, Yue-Cune Chang, Yi-Ching Liu, Chih-Chiang Chiu, Guochuan E Tsai. Arch Gen Psychiatry 2005
208
20

Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, Added to Clozapine for the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial.
Chieh-Hsin Lin, Ching-Hua Lin, Yue-Cune Chang, Yu-Jhen Huang, Po-Wei Chen, Hui-Ting Yang, Hsien-Yuan Lane. Biol Psychiatry 2018
53
20

Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamine.
Michelle Kokkinou, Elaine E Irvine, David R Bonsall, Sridhar Natesan, Lisa A Wells, Mark Smith, Justyna Glegola, Eleanor J Paul, Kyoko Tossell, Mattia Veronese,[...]. Mol Psychiatry 2021
12
20

Neurophysiological Effects of Bitopertin in Schizophrenia.
Joshua T Kantrowitz, Karen A Nolan, Michael L Epstein, Nayla Lehrfeld, Constance Shope, Eva Petkova, Daniel C Javitt. J Clin Psychopharmacol 2017
19
20

Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia.
S G Potkin, Y Jin, B G Bunney, J Costa, B Gulasekaram. Am J Psychiatry 1999
98
20

Targeting glutamate to treat schizophrenia: lessons from recent clinical studies.
Katherine Beck, Daniel C Javitt, Oliver D Howes. Psychopharmacology (Berl) 2016
13
20

Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor.
Hsien-Yuan Lane, Ching-Hua Lin, Michael F Green, Gerhard Hellemann, Chih-Chia Huang, Po-Wei Chen, Rene Tun, Yue-Cung Chang, Guochuan E Tsai. JAMA Psychiatry 2013
129
20

Stigmatization of schizophrenia as perceived by nurses, medical doctors, medical students and patients.
G Serafini, M Pompili, R Haghighat, D Pucci, M Pastina, D Lester, G Angeletti, R Tatarelli, P Girardi. J Psychiatr Ment Health Nurs 2011
48
20

A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophrenia.
Mark Weiser, Uriel Heresco-Levy, Michael Davidson, Daniel C Javitt, Nomi Werbeloff, Ari A Gershon, Yehuda Abramovich, Daniela Amital, Adiel Doron, Shai Konas,[...]. J Clin Psychiatry 2012
66
20


Adjunctive sarcosine plus benzoate improved cognitive function in chronic schizophrenia patients with constant clinical symptoms: A randomised, double-blind, placebo-controlled trial.
Chun-Yuan Lin, Sun-Yuan Liang, Yue-Cune Chang, Shuo-Yen Ting, Ching-Ling Kao, Yu-Hsin Wu, Guochuan E Tsai, Hsien-Yuan Lane. World J Biol Psychiatry 2017
46
20



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.